Sysmex ADR Total Assets 2016-2024 | SSMXY
Sysmex ADR total assets from 2016 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
- Sysmex ADR total assets for the quarter ending June 30, 2024 were $4.008B, a 16.85% increase year-over-year.
- Sysmex ADR total assets for 2024 were $4.099B, a 4.3% increase from 2023.
- Sysmex ADR total assets for 2023 were $3.93B, a 8.71% decline from 2022.
- Sysmex ADR total assets for 2022 were $4.305B, a 11.79% increase from 2021.
| Sysmex ADR Annual Total Assets (Millions of US $) |
|
|---|---|
| 2024 | $4,099 |
| 2023 | $3,930 |
| 2022 | $4,305 |
| 2021 | $3,851 |
| 2020 | $3,571 |
| 2019 | $3,121 |
| 2018 | $3,038 |
| 2017 | $2,498 |
| 2016 | $2,368 |
| Sysmex ADR Quarterly Total Assets (Millions of US $) |
|
|---|---|
| 2024-06-30 | $4,008 |
| 2023-06-30 | $3,909 |
| 2022-06-30 | $3,755 |
| 2021-06-30 | $3,860 |
| 2020-06-30 | $3,430 |
| 2019-06-30 | $3,218 |
| 2018-06-30 | $2,836 |
| 2017-06-30 | $2,561 |
| 2016-06-30 | $2,247 |
| 2016-03-31 | $2,368 |
| 2015-12-31 | $0 |
| 2015-09-30 | $0 |
| 2015-06-30 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $11.599B | $3.197B |
| Sysmex Corporation is engaged in the development, manufacture, import, export and sale of clinical laboratory instruments, reagents and software used in -vitro diagnostics. It also provides clinical laboratory testing of blood, urine and other specimens. The company's product includes instruments and reagents diagnostics for hemostasis, immunochemistry, clinical chemistry, urinalysis and point-of-care testing. Its operating segment consists of Japan, Americas, EMEA, China and Asia Pacific. Sysmex Corporation is headquartered in Kobe, Japan. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $212.467B | 25.92 |
| Intuitive Surgical (ISRG) | United States | $180.733B | 94.49 |
| Alcon (ALC) | Switzerland | $45.462B | 32.00 |
| Edwards Lifesciences (EW) | United States | $40.042B | 24.90 |
| IQVIA Holdings (IQV) | United States | $38.149B | 21.02 |
| IDEXX Laboratories (IDXX) | United States | $33.943B | 39.97 |
| DexCom (DXCM) | United States | $27.225B | 41.00 |
| Waters (WAT) | United States | $22.999B | 34.01 |
| STERIS (STE) | Ireland | $22.270B | 25.99 |
| SONOVA HOLDING (SONVY) | Switzerland | $21.961B | 0.00 |
| Hologic (HOLX) | United States | $19.446B | 20.52 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $11.766B | 13.19 |
| Globus Medical (GMED) | United States | $10.118B | 28.30 |
| Teleflex (TFX) | United States | $9.629B | 15.36 |
| Penumbra (PEN) | United States | $8.808B | 86.28 |
| Masimo (MASI) | United States | $7.841B | 41.99 |
| Glaukos (GKOS) | United States | $7.219B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $5.065B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.244B | 24.06 |
| Inari Medical (NARI) | United States | $2.865B | 0.00 |
| TransMedics (TMDX) | United States | $2.852B | 90.39 |
| Veracyte (VCYT) | United States | $2.687B | 166.57 |
| LivaNova (LIVN) | United Kingdom | $2.661B | 15.36 |
| Nihon Kohden (NHNKY) | Japan | $2.561B | 15.94 |
| Elekta AB (EKTAY) | Sweden | $2.323B | 18.92 |
| Tandem Diabetes Care (TNDM) | United States | $2.151B | 0.00 |
| RxSight (RXST) | United States | $1.896B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.871B | 9.73 |
| Alphatec Holdings (ATEC) | United States | $1.185B | 0.00 |
| Artivion (AORT) | United States | $1.150B | 105.61 |
| OPKO Health (OPK) | United States | $1.032B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.934B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.883B | 15.01 |
| OrthoPediatrics (KIDS) | United States | $0.696B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.684B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.662B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.641B | 16.18 |
| IRadimed (IRMD) | United States | $0.626B | 33.81 |
| AxoGen (AXGN) | United States | $0.622B | 0.00 |
| SiBone (SIBN) | United States | $0.568B | 0.00 |
| Paragon 28 (FNA) | United States | $0.506B | 0.00 |
| CVRx (CVRX) | United States | $0.365B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.359B | 19.62 |
| ClearPoint Neuro (CLPT) | United States | $0.352B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.338B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.299B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.274B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.234B | 0.00 |
| Inogen (INGN) | United States | $0.214B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.210B | 14.62 |
| Nevro (NVRO) | United States | $0.199B | 0.00 |
| NeuroPace (NPCE) | United States | $0.186B | 0.00 |
| Accuray (ARAY) | United States | $0.180B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.177B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.156B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.123B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.122B | 0.00 |
| 908 Devices (MASS) | United States | $0.116B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.104B | 15.51 |
| EDAP TMS S.A (EDAP) | France | $0.100B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.086B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.080B | 0.00 |
| Hyperfine (HYPR) | United States | $0.070B | 0.00 |
| LENSAR (LNSR) | United States | $0.068B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.068B | 0.00 |
| InspireMD (NSPR) | Israel | $0.062B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.051B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.048B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.046B | 0.00 |
| Envoy Medical (COCH) | United States | $0.046B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.045B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.044B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.036B | 0.00 |
| Neuronetics (STIM) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.029B | 0.00 |
| Spectral AI (MDAI) | United States | $0.028B | 0.00 |
| Precision Optics (POCI) | United States | $0.026B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.025B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.019B | 0.00 |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.018B | 0.00 | |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.015B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.014B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.014B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.013B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.013B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.007B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Tenon Medical (TNON) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |